共 322 条
[1]
Steen V(2000)Severe organ involvement in systemic sclerosis with diffuse sceroderma Arthritis Rheum 43 2437-2444
[2]
Medsger TA(2001)Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 89-95
[3]
Medsger TA(2003)Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being Rheum Dis Clin N Am 29 255-273
[4]
Hudson M(2012)Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis J Rheumatol 39 787-794
[5]
Mahler M(2011)Involvement of functional autoantibodies against vascular receptors in systemic sclerosis Ann Rheum Dis 70 530-536
[6]
Pope J(2014)Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis Am J Respir Crit Care Med 190 808-817
[7]
You D(2008)High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis Arthritis Rheum 58 284-291
[8]
Tatibouet S(2014)433-443 Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis N Engl J Med 370 433-443
[9]
Steele R(2013)A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system Cytokine Growth Factor Rev 24 269-283
[10]
Riemekasten G(2018)CCL21 as a potential serum biomarker for pulmonary arterial hypertension in systemic sclerosis Arthritis Rheum 70 1644-1653